Published in Cancer Epidemiol Biomarkers Prev on July 29, 2008
Alcohol consumption before and after breast cancer diagnosis: associations with survival from breast cancer, cardiovascular disease, and other causes. J Clin Oncol (2013) 2.46
Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies. Ann Oncol (2014) 2.35
Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: the life after cancer epidemiology study. J Clin Oncol (2010) 2.31
Time course of risk factors in cancer etiology and progression. J Clin Oncol (2010) 1.46
Low to moderate alcohol intake is not associated with increased mortality after breast cancer. Cancer Epidemiol Biomarkers Prev (2010) 1.08
Post-diagnosis dietary factors and survival after invasive breast cancer. Breast Cancer Res Treat (2011) 1.08
Postdiagnosis alcohol consumption and breast cancer prognosis in the after breast cancer pooling project. Cancer Epidemiol Biomarkers Prev (2012) 0.99
Adherence to Mediterranean diet and risk of cancer: an updated systematic review and meta-analysis of observational studies. Cancer Med (2015) 0.93
Alcohol consumption and survival after breast cancer. Cancer Epidemiol Biomarkers Prev (2009) 0.90
Alcohol intake and mortality among women with invasive breast cancer. Br J Cancer (2012) 0.90
The effect of overweight and nutrition on prognosis in breast cancer. Dtsch Arztebl Int (2011) 0.87
Alcohol consumption and survival after a breast cancer diagnosis: a literature-based meta-analysis and collaborative analysis of data for 29,239 cases. Cancer Epidemiol Biomarkers Prev (2014) 0.83
Pre- and postoperative alcohol consumption in breast cancer patients: impact on early events. Springerplus (2014) 0.80
Alcohol and breast cancer tumor subtypes in a Spanish Cohort. Springerplus (2016) 0.79
Alcohol intake over the life course and breast cancer survival in Western New York exposures and breast cancer (WEB) study: quantity and intensity of intake. Breast Cancer Res Treat (2013) 0.78
Prognostic value of alcohol consumption and some other dietary habits for survival in a cohort of Chinese men with lung cancer. Chin J Cancer (2017) 0.75
Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet (1998) 10.11
Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev (1995) 9.54
Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med (1997) 8.25
The validity of self-reports of alcohol consumption: state of the science and challenges for research. Addiction (2003) 6.23
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev (1993) 4.87
Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA (1998) 4.65
Alcohol consumption and mortality among women. N Engl J Med (1995) 4.22
Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet (1993) 3.72
Alcohol and breast cancer: review of epidemiologic and experimental evidence and potential mechanisms. JAMA (2001) 3.00
Dietary factors and the survival of women with breast carcinoma. Cancer (1999) 2.92
Risk of breast cancer among young women: relationship to induced abortion. J Natl Cancer Inst (1994) 2.51
Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma. Cancer (2001) 2.25
Will mandatory folic acid fortification prevent or promote cancer? Am J Clin Nutr (2004) 2.19
Meta-analysis of studies of alcohol and breast cancer with consideration of the methodological issues. Cancer Causes Control (2006) 2.17
Better breast cancer survival for postmenopausal women who are less overweight and eat less fat. The Iowa Women's Health Study. Cancer (1995) 2.09
Meta-analyses of observational and genetic association studies of folate intakes or levels and breast cancer risk. J Natl Cancer Inst (2006) 2.01
Alcohol consumption and breast cancer risk in the Women's Health Study. Am J Epidemiol (2007) 1.97
A prospective study of folate intake and the risk of breast cancer. JAMA (1999) 1.83
Alcohol consumption and breast cancer risk among women under age 45 years. Epidemiology (1997) 1.76
The etiology of alcohol-induced breast cancer. Alcohol (2005) 1.73
Alcoholic beverage consumption in relation to risk of breast cancer: meta-analysis and review. Cancer Causes Control (1994) 1.68
Dietary folate intake, alcohol, and risk of breast cancer in a prospective study of postmenopausal women. Epidemiology (2001) 1.53
Oral contraceptives and breast cancer risk among younger women. J Natl Cancer Inst (1995) 1.50
The red wine hypothesis: from concepts to protective signalling molecules. Eur Heart J (2007) 1.50
Toxicogenomics and drug discovery: will new technologies help us produce better drugs? Nat Rev Drug Discov (2002) 1.49
Relationship of alcohol intake and sex steroid concentrations in blood in pre- and post-menopausal women: the European Prospective Investigation into Cancer and Nutrition. Cancer Causes Control (2006) 1.47
The relation of reproductive factors to mortality from breast cancer. Cancer Epidemiol Biomarkers Prev (2002) 1.42
The effect of dietary exposures on recurrence and mortality in early stage breast cancer. Breast Cancer Res Treat (1998) 1.26
The relationship between various measures of cigarette smoking and risk of breast cancer among older women 65-79 years of age (United States). Cancer Causes Control (2005) 1.20
The chemistry and biological effects of flavonoids and phenolic acids. Ann N Y Acad Sci (1998) 1.19
Diet and risk for breast cancer recurrence and survival. Breast Cancer Res Treat (1999) 1.18
Effect of ethanol on proliferation and estrogen receptor-alpha expression in human breast cancer cells. Cancer Lett (2001) 1.12
Breast cancer survival in African American women: is alcohol consumption a prognostic indicator? Cancer Causes Control (2002) 1.11
Cytokeratin labeling of breast cancer cells extracted from paraffin-embedded tissue for bivariate flow cytometric analysis. Cytometry (1996) 1.08
Alcohol consumption and breast cancer stage at diagnosis. Alcohol Clin Exp Res (1998) 1.06
Effects of dietary folate on the development and progression of mammary tumors in rats. Carcinogenesis (2005) 1.05
Risk factors for fatal breast cancer in African-American women and White women in a large US prospective cohort. Am J Epidemiol (2005) 1.00
Net effect of oral contraceptive use on the risk of cancer in women in the United States. Obstet Gynecol (1995) 0.91
Do insulin-like growth factors mediate the effect of alcohol on breast cancer risk? Med Hypotheses (1999) 0.89
Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med (2003) 6.47
Oral contraceptives and the risk of breast cancer. N Engl J Med (2002) 4.85
High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer. Genome Biol (2007) 4.70
Use of antihypertensive medications and breast cancer risk among women aged 55 to 74 years. JAMA Intern Med (2013) 4.36
Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer (2004) 4.04
Projecting individualized absolute invasive breast cancer risk in African American women. J Natl Cancer Inst (2007) 3.93
Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000. Cancer (2004) 3.40
Variation of breast cancer risk among BRCA1/2 carriers. JAMA (2008) 3.30
Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. Cancer Res (2006) 3.06
Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998. J Clin Oncol (2003) 3.05
Relationship between long durations and different regimens of hormone therapy and risk of breast cancer. JAMA (2003) 3.04
Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA. Breast Cancer Res Treat (2008) 2.97
Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer. Nat Genet (2009) 2.85
Factors contributing to mammography failure in women aged 40-49 years. J Natl Cancer Inst (2004) 2.84
Array comparative genomic hybridization analysis of genomic alterations in breast cancer subtypes. Cancer Res (2004) 2.80
Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease. Int J Cancer (2005) 2.79
FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation. Hum Mol Genet (2009) 2.62
Reproductive and hormonal risk factors for postmenopausal luminal, HER-2-overexpressing, and triple-negative breast cancer. Cancer (2008) 2.56
Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older. Cancer Epidemiol Biomarkers Prev (2002) 2.50
Relationship between potentially modifiable lifestyle factors and risk of second primary contralateral breast cancer among women diagnosed with estrogen receptor-positive invasive breast cancer. J Clin Oncol (2009) 2.44
Active smoking and the risk of estrogen receptor-positive and triple-negative breast cancer among women ages 20 to 44 years. Cancer (2014) 2.43
Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA (2003) 2.24
The NICHD Women's Contraceptive and Reproductive Experiences Study: methods and operational results. Ann Epidemiol (2002) 2.21
Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years. Cancer (2003) 2.20
The epidemiology of triple-negative breast cancer, including race. Cancer Causes Control (2009) 2.14
Body mass index, weight, and oral contraceptive failure risk. Obstet Gynecol (2005) 2.07
Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study. Breast Cancer Res (2004) 2.03
Risk factors for triple-negative breast cancer in women under the age of 45 years. Cancer Epidemiol Biomarkers Prev (2009) 2.00
Neonatal vitamin D and childhood brain tumor risk. Int J Cancer (2014) 1.97
Validity of models for predicting BRCA1 and BRCA2 mutations. Ann Intern Med (2007) 1.94
Racial and ethnic disparities in cervical cancer incidence rates in the United States, 1992-2003. Cancer Causes Control (2007) 1.92
Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study. J Natl Cancer Inst (2010) 1.91
A population-based study of squamous cell vaginal cancer: HPV and cofactors. Gynecol Oncol (2002) 1.90
Relationship between menopausal hormone therapy and risk of ductal, lobular, and ductal-lobular breast carcinomas. Cancer Epidemiol Biomarkers Prev (2008) 1.88
A validation study of patient interview data and pharmacy records for antihypertensive, statin, and antidepressant medication use among older women. Am J Epidemiol (2004) 1.85
Breast cancers among very young premenopausal women (United States). Cancer Causes Control (2003) 1.80
Environment or host?: A case-control study of risk factors for Mycobacterium avium complex lung disease. Am J Respir Crit Care Med (2012) 1.78
Lifetime recreational exercise activity and breast cancer risk among black women and white women. J Natl Cancer Inst (2005) 1.75
Association between mammographic breast density and breast cancer tumor characteristics. Cancer Epidemiol Biomarkers Prev (2005) 1.69
A genome-wide association study of upper aerodigestive tract cancers conducted within the INHANCE consortium. PLoS Genet (2011) 1.68
Changes in breast cancer incidence rates in the United States by histologic subtype and race/ethnicity, 1995 to 2004. Cancer Epidemiol Biomarkers Prev (2007) 1.67
Characteristics of telephone survey respondents according to willingness to participate. Am J Epidemiol (2003) 1.63
Do thyroid disorders increase the risk of breast cancer? Cancer Epidemiol Biomarkers Prev (2002) 1.62
Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma. Cancer (2002) 1.62
Genetic polymorphisms in the catechol estrogen metabolism pathway and breast cancer risk. Cancer Epidemiol Biomarkers Prev (2009) 1.62
Long-term statin use and risk of ductal and lobular breast cancer among women 55 to 74 years of age. Cancer Epidemiol Biomarkers Prev (2013) 1.59
Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001. Cancer Epidemiol Biomarkers Prev (2005) 1.59
Infertility drugs and the risk of breast cancer: findings from the National Institute of Child Health and Human Development Women's Contraceptive and Reproductive Experiences Study. Fertil Steril (2003) 1.58
Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study. Int J Radiat Oncol Biol Phys (2008) 1.58
Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001. Cancer (2006) 1.56
Body size and risk of luminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev (2008) 1.53
Feasibility of including cellular telephone numbers in random digit dialing for epidemiologic case-control studies. Am J Epidemiol (2010) 1.52
The sex ratio of pregnancies complicated by hospitalisation for hyperemesis gravidarum. BJOG (2004) 1.51
Breast cancer risk and hormone receptor status in older women by parity, age of first birth, and breastfeeding: a case-control study. Cancer Epidemiol Biomarkers Prev (2008) 1.50
General and abdominal obesity and survival among young women with breast cancer. Cancer Epidemiol Biomarkers Prev (2006) 1.47
Reproductive factors and risk of breast carcinoma in a study of white and African-American women. Cancer (2004) 1.46
The relation of reproductive factors to mortality from breast cancer. Cancer Epidemiol Biomarkers Prev (2002) 1.42
Breast cancer receptor status: do results from a centralized pathology laboratory agree with SEER registry reports? Cancer Epidemiol Biomarkers Prev (2009) 1.41
Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study. Hum Mutat (2010) 1.40
Use of four biomarkers to evaluate the risk of breast cancer subtypes in the women's contraceptive and reproductive experiences study. Cancer Res (2010) 1.40
Comprehensive analysis of HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 loci and squamous cell cervical cancer risk. Cancer Res (2008) 1.40